CO6491080A2 - Anillo vaginal de gradiente multi-capa - Google Patents

Anillo vaginal de gradiente multi-capa

Info

Publication number
CO6491080A2
CO6491080A2 CO12011321A CO12011321A CO6491080A2 CO 6491080 A2 CO6491080 A2 CO 6491080A2 CO 12011321 A CO12011321 A CO 12011321A CO 12011321 A CO12011321 A CO 12011321A CO 6491080 A2 CO6491080 A2 CO 6491080A2
Authority
CO
Colombia
Prior art keywords
vaginal ring
layer gradient
application
pharmaceutically active
layer
Prior art date
Application number
CO12011321A
Other languages
English (en)
Spanish (es)
Inventor
Bruce Variano
Jeffrey Speck
Maria Teresa Sallent
Simone Evans
Original Assignee
Population Council Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Population Council Inc filed Critical Population Council Inc
Publication of CO6491080A2 publication Critical patent/CO6491080A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
CO12011321A 2009-07-21 2012-01-25 Anillo vaginal de gradiente multi-capa CO6491080A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27139109P 2009-07-21 2009-07-21

Publications (1)

Publication Number Publication Date
CO6491080A2 true CO6491080A2 (es) 2012-07-31

Family

ID=42236498

Family Applications (1)

Application Number Title Priority Date Filing Date
CO12011321A CO6491080A2 (es) 2009-07-21 2012-01-25 Anillo vaginal de gradiente multi-capa

Country Status (14)

Country Link
US (1) US8753667B2 (enExample)
EP (1) EP2456421B1 (enExample)
JP (1) JP5690826B2 (enExample)
CN (1) CN102497855B (enExample)
AU (1) AU2010274946B2 (enExample)
BR (1) BR112012001353B8 (enExample)
CA (1) CA2767967C (enExample)
CO (1) CO6491080A2 (enExample)
DK (1) DK2456421T3 (enExample)
ES (1) ES2626156T3 (enExample)
IN (1) IN2012DN00711A (enExample)
MX (1) MX2012000948A (enExample)
WO (1) WO2011011099A1 (enExample)
ZA (1) ZA201200809B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
WO2012121767A1 (en) * 2011-03-09 2012-09-13 Arstat, Inc. Treatment of uterine fibroids by intravaginal administration of a low dose of selective progesterone receptor modulator (sprm), anti-progestin, or anti-progestational agent
FR3005417B1 (fr) * 2013-05-10 2015-05-22 Blaise Francois Figuereo Anneau vaginal tri-reservoir, a retro-largage compatible avec les caracteristiques des molecules actives qu'il contient
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
US10413504B2 (en) 2013-12-11 2019-09-17 Merck Sharp & Dohme Corp. Intravaginal ring drug delivery system
DK2982352T3 (en) 2014-06-28 2018-11-26 Laboratorios Andromaco S A CERVICALLY PESSAR CONTAINING PROGESTERON FOR EXTENDED, LONG AND CONTINUOUS RELEASE USED TO PREVENT EARLY BIRTHS
US9943146B2 (en) 2015-05-27 2018-04-17 Qalo Llc Compression molded silicone ring
CN107847019A (zh) * 2015-07-14 2018-03-27 恰罗有限责任公司 压缩模制的有机硅戒指
UA124382C2 (uk) * 2015-12-21 2021-09-08 Баєр Ой Спосіб виготовлення пристрою для доставки лікарського засобу
EP3272333A1 (en) 2016-07-22 2018-01-24 Chemo Research, S.L. Vaginal composition comprising a combination of estrogen and vitamin d
CN106913412B (zh) * 2017-03-01 2023-09-22 上海市嘉定区妇幼保健院 易放易取式子宫托
CN111989068B (zh) 2018-05-24 2024-10-25 塞拉尼斯伊娃高性能聚合物公司 用于持续释放大分子药物化合物的可植入器件
CN111971026A (zh) 2018-05-24 2020-11-20 塞拉尼斯伊娃高性能聚合物公司 用于持续释放大分子药物化合物的可植入器件
EP3803866A4 (en) 2018-05-24 2022-03-16 Nureva Inc. METHOD, APPARATUS, AND COMPUTER READABLE MATERIALS FOR MANAGING SEMI-CONSTANT (PERSISTENT) SOUND SOURCES IN MICROPHONE CATCH/HOME AREAS
US10918649B2 (en) 2019-06-21 2021-02-16 The Population Council, Inc. System for providing birth control
WO2021096926A1 (en) * 2019-11-12 2021-05-20 Poly-Med, Inc. Contraceptive medical devices
DE102021100916A1 (de) 2021-01-18 2022-07-21 Carl Freudenberg Kg Verfahren zur Herstellung eines Bauteils, Werkzeug zur Durchführung des Verfahrens und Bauteil, das durch das Verfahren hergestellt ist
BR112023022439A2 (pt) 2021-04-26 2023-12-26 Celanese Eva Performance Polymers Llc Dispositivo implantável para liberação sustentada de um composto de fármaco macromolecular

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL152819B (nl) 1949-04-07 Swift & Co Werkwijze voor het continu bereiden van mono-ammoniumdiwaterstoffosfaatdeeltjes en zo verkregen deeltjes.
US2863846A (en) 1950-05-04 1958-12-09 Dow Corning Organo silyl-silica filled siloxane elastomers and process for producing same
US2890188A (en) 1951-12-17 1959-06-09 Dow Corning Siloxane elastomers compounded with hydroxylated silanes
NL91756C (enExample) 1953-11-19
GB804199A (en) 1955-12-22 1958-11-12 Midland Silicones Ltd Organosiloxane compositions
GB798669A (en) 1956-12-12 1958-07-23 Midland Silicones Ltd Improvements in or relating to organosiloxane elastomer foams
US2927907A (en) 1957-01-07 1960-03-08 Dow Corning Siloxane elastomers
US3022951A (en) 1957-05-14 1962-02-27 Ibm Full adder
US3035016A (en) 1959-03-16 1962-05-15 Dow Corning Acyloxy siloxanes and a method of using the
US3545439A (en) 1968-01-04 1970-12-08 Upjohn Co Medicated devices and methods
US4155991A (en) 1974-10-18 1979-05-22 Schering Aktiengesellschaft Vaginal ring
IL48277A (en) 1974-10-18 1978-03-10 Schering Ag Vaginal ring
US3995634A (en) 1975-12-02 1976-12-07 The Procter & Gamble Company Vaginal cavity dispensing means and method
US3995633A (en) 1975-12-02 1976-12-07 The Procter & Gamble Company Vaginal Medicament dispensing device
US4237885A (en) 1978-10-23 1980-12-09 Alza Corporation Delivery system with mated members for storing and releasing a plurality of beneficial agents
US4292965A (en) * 1978-12-29 1981-10-06 The Population Council, Inc. Intravaginal ring
DE3040978A1 (de) 1980-10-28 1982-05-27 Schering Ag, 1000 Berlin Und 4619 Bergkamen Vaginalring
EP0180264A1 (en) 1984-10-12 1986-05-07 Akzo N.V. Release system for two or more active substances
FR2598652B1 (fr) 1986-05-16 1988-08-05 Figuereo Blaise Machine d'extrusion simultanee de plusieurs matieres
US4922928A (en) 1988-08-17 1990-05-08 Michael Burnhill Vaginal device
ES2166894T3 (es) 1995-07-04 2002-05-01 Akzo Nobel Nv Dispositivos anulares.
US5972372A (en) * 1996-07-31 1999-10-26 The Population Council, Inc. Intravaginal rings with insertable drug-containing core
IL123813A0 (en) 1997-04-11 1998-10-30 Akzo Nobel Nv Drug delivery system for two or more active substances
EP1372605A2 (en) 2001-03-27 2004-01-02 Galen (Chemicals) Limited Intravaginal drug delivery devices for the administration of an antimicrobial agent
US7833545B2 (en) 2003-04-29 2010-11-16 The General Hospital Corporation Methods and devices for the sustained release of multiple drugs
TWI336627B (en) * 2003-05-23 2011-02-01 Organon Nv Drug delivery system,and use and manufacturing method thereof
CN1899643B (zh) 2005-07-20 2010-12-29 上海市计划生育科学研究所 含有抗雌激素和抗孕激素复合制剂的阴道环或宫内释药装置及其制药用途
US7824383B2 (en) 2006-06-16 2010-11-02 Family Health International Vaginal drug delivery system and method

Also Published As

Publication number Publication date
US20120148655A1 (en) 2012-06-14
JP2012533401A (ja) 2012-12-27
BR112012001353B1 (pt) 2020-04-14
BR112012001353B8 (pt) 2021-05-25
AU2010274946A1 (en) 2012-03-01
CA2767967C (en) 2014-10-21
HK1169614A1 (en) 2013-02-01
AU2010274946B2 (en) 2013-09-12
IN2012DN00711A (enExample) 2015-06-19
JP5690826B2 (ja) 2015-03-25
BR112012001353A2 (pt) 2016-04-05
MX2012000948A (es) 2012-02-28
US8753667B2 (en) 2014-06-17
EP2456421A1 (en) 2012-05-30
CN102497855A (zh) 2012-06-13
DK2456421T3 (en) 2017-06-06
ES2626156T3 (es) 2017-07-24
CN102497855B (zh) 2013-12-25
CA2767967A1 (en) 2011-01-27
ZA201200809B (en) 2012-10-31
EP2456421B1 (en) 2017-04-05
WO2011011099A1 (en) 2011-01-27

Similar Documents

Publication Publication Date Title
CO6491080A2 (es) Anillo vaginal de gradiente multi-capa
CL2020002695A1 (es) Péptidos macrocíclicos contra actinetobacter baumannii
AR083561A1 (es) Preparacion de una construccion antigenica
BR112015021908A8 (pt) implante, método de realizar uma ostomia, e método de fabricar um implante
MX373666B (es) Compensador de grosor de tejido que comprende una pluralidad de capsulas.
SV2015005115A (es) Derivados de la pirazolopirrolidina y su uso en el tratamiento de enfermedades
CR20130607A (es) Estructura tubular y método para fabricarla
CO6660502A2 (es) Compuestos macrocíclicos como inhibidores de quinasa trk
MX354144B (es) Metodo, fabricacion y uso de productos medicos que liberan sustancia activa para mantener vasos sanguineos abiertos.
BR112013019223A2 (pt) forma de dosagem para liberação modificada, processo para a fabricação de um comprimido e processo para a fabricação de uma forma de dosagem oral
CL2013000063A1 (es) Un método para tratar a un sujeto que comprende administrar n-etil-n-fenil1,2-dihidroxi-4-hodroxi-5-cloro-1-metil-2-oxoquinolina-3-carboxamida opcionalmente deuterada, para el tratamiento de una enfermedad autoinmunitaria; una mezcla de los mismos; composición farmaceutica y su proceso de preparacion.
CL2011000935A1 (es) Composicion farmaceutica que comprende acetaminofeno y un material de tramadol complejo, que exhibe una liberacion sostenida y coordinada a traves de una capa de liberacion sostenida y otra de liberacion inmediata; metodo de preparacion;y el uso de un material complejo de tramadol y acetaminofeno para preparar un medicamento para el tratamiento del dolor.
CR20160518A (es) Compuestos para tratar atrofia muscular espinal
BR112013024585A8 (pt) formas de dosagem farmacêutica de liberação controlada
DOP2012000170A (es) Proceso para la fabricacion de un agente farmaceuticamante activo
AR081868A1 (es) Vectores y secuencias de sulfamidasa humana para el tratamiento de mucopolisacaridosis
CR20120585A (es) Una forma cristalina de (r)-7cloro-n-(quinuclidin-3-il) benzo [b] tiofeno-2-carboxamida monohidrato
PA8806201A1 (es) Imidazo pirazinas fusionadas
CR20130530A (es) Derivados glucósidos y sus usos para el tratamiento de la diabetes
CO6361926A2 (es) Derivados de anilina-pirimidina sustituidos con sulfoximina como inhibidores de quinasas dependientes de ciclina (cdk), produccion y uso de los mismos como productos medicinales
MX2014007530A (es) Implemento para la higiene de los tejidos blandos y el cuidado oral.
CR20150266A (es) Formulaciones de liberación modificada para oprozomib
DOP2009000285A (es) (oxazolidinon-5-il-metil)-2-tiofen-carboxamidas sustituidas y su uso en el campo de la coagulacion sanguinea.
UY34786A (es) Procedimiento para la fabricación de una forma farmacéutica que comprende nifedipino y candesartan cilexetilo
CO2017007383A2 (es) Métodos para utilizar oligonucleótidos antisentido para smad7

Legal Events

Date Code Title Description
FG Application granted